background
interferongamma
releas
assay
igra
specif
tuberculin
skin
test
discrimin
tuberculosi
tb
nontubercul
mycobacteri
ntm
diseas
perform
retrospect
studi
evalu
perform
tspottb
patient
ntm
diseas
method
march
nov
total
patient
ntm
diseas
tspottb
perform
enrol
patient
definit
ntm
diseas
probabl
diseas
clinicopatholog
characterist
review
analyz
cultur
mycobacteria
perform
indirect
proport
method
lj
medium
use
firstlin
drug
suscept
test
tspottb
assay
perform
accord
manufactur
instruct
data
express
mean
standard
deviat
continu
variabl
number
percentag
categor
variabl
test
use
comparison
proport
result
averag
age
year
rang
year
male
tbpcr
posit
isol
mycobacterium
intracellular
ten
mycobacterium
chelona
seven
mycobacterium
fortuitum
fiftytwo
patient
ntm
lung
diseas
five
pleural
diseas
one
lymphaden
total
posit
tspottb
among
whole
group
probabl
definit
probabl
case
tspottb
assay
posit
definit
case
definit
case
posit
statist
differ
posit
rate
p
conclus
studi
show
signific
portion
ntm
diseas
tspottb
posit
china
although
tspottb
use
diagnost
method
differenti
tb
ntm
diseas
china
igra
assay
show
limit
valu
discrimin
addit
research
need
investig
associ
tb
infect
treatment
ntm
patient
nontubercul
mycobacteria
ntm
ubiquit
microorgan
found
variou
environ
ntm
caus
asymptomat
infect
symptomat
diseas
lung
common
site
ntm
infect
noteworthi
preval
ntm
diseas
increasingli
report
worldwid
china
frequent
caus
organ
ntm
mycobacterium
intracellular
mycobacterium
kansasii
mycobacterium
fortuitum
current
lack
random
clinic
trial
guid
treatment
result
treatment
strategi
larg
base
expert
opinion
meanwhil
diagnosi
pulmonari
ntm
diseas
significantli
delay
china
ntm
diseas
share
clinic
sign
tuberculosi
tb
caus
clinic
dilemma
differenti
ntm
infect
tb
tuberculin
skin
test
tst
remain
use
detect
latent
tb
infect
adjunct
test
activ
tb
howev
tst
suffer
fals
posit
ntm
diseas
previou
bcgvaccin
interferongamma
releas
assay
igra
tspottb
quantiferontb
gold
test
qftgt
specif
base
cell
mediat
releas
stimul
specif
mycobacterium
tuberculosi
mtb
antigen
test
better
specif
worldwid
without
crossreact
ntm
bcg
higher
sensit
compar
tst
detect
activ
tb
latent
tb
infect
tspottb
assay
base
respons
mtb
specif
peptid
antigen
locat
region
differ
present
mycobacteria
belong
mtb
complex
mtb
mycobacterium
africanum
mycobacterium
bovi
mycobacterium
canettii
mycobacterium
capra
mycobacterium
microti
mycobacterium
pinnipedii
mycobacterium
mungi
mycobacterium
orygi
ntm
speci
also
share
mtb
complex
mycobacterium
gastri
mycobacterium
kansasii
mycobacterium
marinum
mycobacterium
riyadhens
mycobacterium
szulgai
therefor
infect
strain
may
result
posit
result
tspottb
assay
due
high
specif
igra
studi
suggest
use
discrimin
infect
tb
ntm
goal
retrospect
studi
evalu
perform
tspottb
patient
ntm
diseas
high
tbburden
countri
protocol
approv
ethic
committe
shandong
provinci
chest
hospit
written
inform
consent
requir
retrospect
natur
investig
march
nov
total
patient
ntm
diseas
tspottb
perform
enrol
patient
definit
ntm
diseas
probabl
diseas
clinicopatholog
characterist
review
analyz
case
defin
definit
accord
atsidsa
criteria
diseas
clinic
criteria
least
two
separ
posit
cultur
sputum
sampl
least
one
posit
cultur
bronchial
lavag
lung
biopsi
patient
posit
ntm
cultur
compat
clinic
syndrom
term
probabl
cultur
mycobacteria
perform
use
medium
lj
method
indirect
proport
method
lj
medium
use
firstlin
drug
suscept
test
dst
tspottb
assay
oxford
immunot
ltd
edinburgh
uk
perform
accord
manufactur
instruct
briefli
peripher
blood
mononuclear
cell
separ
whole
blood
sampl
incub
antigen
secret
cytokin
sensit
cell
captur
specif
antibodi
membran
final
cytokin
detect
chromogen
spot
assay
follow
manufactur
instruct
result
test
categor
posit
neg
spot
count
statist
analysi
carri
use
spss
softwar
data
express
mean
standard
deviat
continu
variabl
number
percentag
categor
variabl
test
use
comparison
proport
statist
test
tabl
show
characterist
particip
studi
averag
age
year
rang
year
male
one
hundr
percent
hivneg
tbpcr
posit
posit
acidfast
bacillu
stain
ntm
cultur
sputum
pleural
effus
bronchial
brush
tissu
thirtyfour
isol
mycobacterium
intracellular
ten
mycobacterium
chelona
seven
mycobacterium
fortuitum
four
mycobacterium
kansasii
one
mycobacterium
avium
one
mycobacterium
scrofulaceum
one
mycobacterium
terra
phenotyp
dst
perform
isol
isol
resist
isoniazid
resist
rifampin
resist
streptomycin
resist
ethambutol
resist
four
drug
fiftytwo
patient
ntm
lung
diseas
five
pleural
diseas
one
lymphaden
thirtyseven
patient
cough
fever
dyspnea
five
hemoptysi
eight
patient
asymptomat
admit
abnorm
chest
xray
seven
patient
contact
histori
tb
patient
famili
total
posit
tspottb
among
ntm
group
probabl
definit
probabl
case
tspottb
assay
posit
definit
case
definit
case
posit
statist
differ
posit
rate
p
ntm
strain
mycobacterium
intracellular
case
posit
tspottb
assay
seven
probabl
nine
definit
mycobacterium
chelona
case
tspottb
posit
three
probabl
four
definit
mycobacterium
fortuitum
case
tspottb
posit
definit
china
one
high
tbburden
countri
mtb
remain
main
caus
pulmonari
mycobacteria
diseas
differenti
ntm
infect
tb
difficult
sinc
igra
potenti
differ
tb
ntm
diseas
aim
evalu
use
tspottb
discrimin
china
surprisingli
studi
high
proport
ntm
patient
found
tspottb
posit
result
impli
tb
infect
among
ntm
diseas
common
china
tspottb
limit
valu
discrimin
ntm
diseas
tb
china
diagnosi
ntm
diseas
remain
reli
routin
method
cultur
best
knowledg
first
report
evalu
perform
igra
ntm
diseas
high
tbburden
countri
previous
thought
patient
get
one
kind
diseas
ntm
tb
nonetheless
develop
immunolog
molecular
method
studi
also
found
patient
tspottb
posit
ntm
patient
tbpcr
posit
howev
studi
conduct
hospit
show
health
care
worker
overal
posit
rate
tspottb
test
ci
moreov
posit
control
group
includ
cultur
confirm
tb
patient
age
male
posit
tspottb
statist
analysi
show
posit
tspottb
ntm
diseas
lower
posit
control
data
publish
therefor
find
direct
proof
mix
infect
coexist
tb
ntm
import
clinic
signific
patient
mix
infect
may
one
reason
may
lead
failur
therapi
ntm
diseas
caution
exercis
exampl
five
patient
retreat
ntm
diseas
studi
usual
ntm
isol
resist
firstlin
antitb
drug
therefor
drug
would
nt
first
choic
treatment
tb
patient
sinc
coinfect
exist
drug
sensit
tb
resist
ntm
stain
reconsid
moreov
unaccur
diagnosi
ntm
diseas
made
due
presenc
ntm
sometim
lead
inappropri
treatment
addit
mix
tb
ntm
may
also
present
clinic
problem
cultur
dst
failur
recogn
tb
overestim
sever
drug
resist
kendal
et
al
report
signific
portion
pulmonari
tb
patient
identifi
ntm
particularli
patient
cavit
born
us
anoth
us
studi
identifi
pulmonari
tb
patient
ntm
speci
simultan
detect
mtb
ntm
specimen
possibl
ntm
may
present
colon
pathogen
ntm
ubiquit
environ
isol
frequent
immunocompromis
patient
hivinfect
individu
patient
immunosuppress
treatment
exampl
antitnf
drug
corticosteroid
thu
analysi
perform
hwang
sm
et
al
report
signific
portion
ntm
patient
identifi
tb
ten
patient
histori
tb
mix
cultur
ntm
mtb
present
repeatedli
patient
research
first
report
address
issu
mix
infect
tb
ntm
evalu
diagnost
role
igra
discrimin
tb
ntm
diseas
sever
studi
perform
low
tbburden
countri
show
igra
hold
potenti
discrimin
ntm
tb
infect
japanes
studi
show
qftgt
mean
sensit
mean
specif
test
use
diagnost
method
differenti
hermansen
ts
et
al
found
qftgt
posit
patient
definit
ntm
diseas
patient
definit
diseas
infect
ntm
without
region
studi
found
signific
portion
ntm
diseas
tspottb
posit
china
similar
result
report
author
nt
address
issu
contribut
crossreact
mean
china
igra
assay
show
limit
valu
discrimin
tb
ntm
diseas
studi
six
kind
ntm
mycobacterium
intracellular
mycobacterium
chelona
mycobacterium
fortuitum
mycobacterium
kansasii
mycobacterium
avium
mycobacterium
terra
isol
mycobacterium
kansasii
known
express
studi
limit
could
impact
result
bia
common
retrospect
studi
howev
bia
studi
minim
consecut
case
enrol
patient
equal
chanc
particip
studi
sampl
size
small
caution
need
interpret
result
final
current
diagnost
method
could
nt
identifi
true
activ
tb
tspottb
tbpcr
posit
case
therefor
suggest
choos
appropri
regim
ntm
case
tspottb
tbpcr
posit
think
firstlin
antitb
drug
consid
studi
show
signific
portion
ntm
diseas
tspottb
posit
china
although
tspottb
use
diagnost
method
differenti
tb
ntm
diseas
lowtb
burden
countri
china
igra
assay
show
limit
valu
discrimin
addit
research
need
investig
associ
tb
infect
treatment
ntm
diseas
